ArticleNaunyn-Schmiedeberg's archives of pharmacology2026
Ruminococcaceae promotes the NLRP3/ASC/Caspase-1 axis-mediated pyroptotic signaling in papillary thyroid carcinoma by upregulating RBM15 to increase the N6-methyladenosine methylation modulation of NLRP3.
Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. The "mild" clinical behavior of PTC often leads to underestimation of the complexity of its treatment. Ruminococcus (Rum) is a cancer-related intestinal flora. Further study on its functional mechanism is expected to provide a new direction for microbial targeted therapy of cancer. Therefore, the aim of this study was to investigate the therapeutic effect of Rum on PTC and its related mechanism. Rum upregulated the mRNA expression level of RBM15 in BCPAP and KTC-1 cells, decreased their cell viability, promoted pyroptotic signaling, and inhibited their invasion and migration, as well as reduced the volume and weight of tumor tissue and aggravated their pathological injuries. Moreover, Rum downregulated MMP2 and MMP9 mRNA and protein expression levels and upregulated IFN-γ, IL-1β, and IL-18 expression levels, as well as NLRP3, ASC, Caspase-1 mRNA and protein expression levels, the m6A methylation content, and the m6A methylation of NLRP3 in vivo and in vitro. In addition, knocking down RBM15 effectively reversed the effects of Rum mentioned above in vivo and in vitro. Mechanistically, Rum activates the NLRP3/ASC/Caspase-1 axis-mediated pyroptotic signaling in PTC by upregulating RBM15 to increase the N6-methyladenosine methylation modulation of NLRP3, thereby providing a novel strategy and target for the clinical treatment of PTC.
Indexed as
Identifiers
41627386What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.